What does structured rehab and who offers it

The short version: structured rehab for long COVID works for some symptoms, but the evidence is fragmented, mostly short-term, and the programs that offer it are not standardized or widely available.

The strongest evidence comes from a 2025 Korean clinical practice guideline that says general and respiratory rehabilitation consistently improves dyspnea, exercise capacity, fatigue, and quality of life, based on multiple RCTs and meta-analyses [5]. A 2022 RCT of 52 men found that adding manual diaphragm release to inspiratory muscle training for six weeks produced large gains: inspiratory muscle strength improved by 39.5 cmH2O versus 3.5 in controls, and the six-minute walk distance improved by 56.5 meters versus 16.5 [6]. A narrative review found that high-intensity interval training (three times a week for three months) improved six-minute walk distance by 90 to 221 meters in previously hospitalized patients, reaching 76 to 91 percent of predicted normal values [7].

But these are small studies. The diaphragm trial had 52 men only [6]. The high-intensity interval study had 22 patients [7]. The evidence says rehab works for dyspnea and exercise capacity, but the studies are too small and short to tell you whether it changes the underlying disease trajectory or just temporarily pushes symptoms down.

Who offers it varies by country and system. The Korean guideline recommends multidisciplinary care [5]. A 2024 multinational study found that only 30 percent of healthcare systems had specialized long COVID clinics, and 45 percent offered rehabilitation [2]. A 2021 report from Bangladesh described a post-COVID clinic at Dhaka Medical College Hospital that had followed over 600 patients with a multidisciplinary team including pulmonology, neurology, psychiatry, and physical medicine [13]. A 2024 UK Delphi consensus among patients and clinicians called for integrated, multidisciplinary, patient-centered care but noted that most systems are not set up for it [19].

The evidence that exists is mostly about short-term functional gains in small, selected groups. No large trial has compared structured rehab to no rehab in a broad long COVID population with long-term follow-up. The absence of that trial is the most important gap here.

My call: structured rehab improves dyspnea and exercise capacity in the short term, but the evidence is too thin to say it produces lasting recovery for most patients, and most healthcare systems do not offer it in a standardized way. Confidence: moderate for short-term symptom improvement, low for long-term recovery.